Cognitive improvement via cortical cannabinoid receptors and choline-containing lipidsBRITISH JOURNAL OF PHARMACOLOGYIF7.72024-11-030OAAI
Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's diseaseNEUROBIOLOGY OF DISEASEIF5.62024-11-011OAAI
Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndromeELIFEIF02022-10-113OA
Handling and novel object recognition modulate fear response and endocannabinoid signaling in nucleus basalis magnocellularisEUROPEAN JOURNAL OF NEUROSCIENCEIF2.42022-03-172OAAI
Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's DiseaseACS CHEMICAL NEUROSCIENCEIF3.92021-05-269OAAI
Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's DiseaseJOURNAL OF ALZHEIMERS DISEASEIF3.12018-05-2615PREAI